CMPS COMPASS Pathways Plc - American Depository Shares

NAS · US · Healthcare · Medical Care Facilities · compasspathways.com

11.55USD-2.94%Mkt Cap: 1.65B $P/E: —Today

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial…

Industry Peers

Medical Care Facilities

Screen all

HCA

HCA Healthcare, Inc. Common Stock

$94.66BUSDP/E 14.3

FRE

Fresenius SE & Co. KGaA

$26.85BUSDP/E 15.8

THC

Tenet Healthcare Corporation Common Stock

$20.82BUSDP/E 10.0

FME

Fresenius Medical Care AG

$11.75BUSDP/E 12.1

FMS

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

$11.84BUSDP/E 11.8

EHC

Encompass Health Corporation Common Stock

$11.82BUSDP/E 20.0

DVA

DaVita Inc. Common Stock

$11.47BUSDP/E 15.1

UHS

Universal Health Services, Inc. Common Stock

$10.36BUSDP/E 7.2

ENSG

The Ensign Group, Inc. - Common Stock

$10.01BUSDP/E 26.9

PACS

PACS Group, Inc. Common Stock

Concentra Group Holdings Parent, Inc. Common Stock

$4.55BUSDP/E 23.0

LFST

LifeStance Health Group, Inc. - Common Stock

National HealthCare Corporation Common Stock

$3.57BUSDP/E 25.6

OPCH

Option Care Health, Inc. - Common Stock

$3.39BUSDP/E 17.2

AVAH

Aveanna Healthcare Holdings Inc. - Common Stock

$2.75BUSDP/E 10.0

GRDN

Guardian Pharmacy Services, Inc. Class A Common Stock

$2.68BUSDP/E 40.8

ACHC

Acadia Healthcare Company, Inc. - Common Stock

$2.61BUSD

BKD

Brookdale Senior Living Inc. Common Stock

$2.59BUSD

Key Statistics

Company

Market Cap1.65B USD

Enterprise Value1.27B USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-287.86M USD

Revenue/Share—

Last Price11.55 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees156

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-8.30

PEG—

EV/EBITDA-6.84

EV/Revenue—

P/S—

P/B19.10

EPS (TTM)-3.76

EPS (Forward)-1.43

52W Range

4.88061% of range15.87

52W High15.87 USD

52W Low4.880 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE544.70%

ROA-136.85%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-157.24M USD

CapEx (TTM)—

FCF Margin—

FCF Yield15.17%

Net Debt-378.67M USD

Net Debt/EBITDA2.04

Balance Sheet

Debt/Equity-0.66

Current Ratio1.29

Quick Ratio1.22

Book Value/Sh0.62 USD

Cash/Share3.13 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)23.75 USD

Upside (mean)+105.6%

Target Range13.00 USD – 65.00 USD

13.00+105.6% to mean65.00

# Analysts16

Ownership

Shares Out.138.48M

Float106.97M

Insiders7.62%

Institutions68.56%

Short Interest

Short Ratio6.1d

Short % Float11.14%

Short % Out.11.00%

Shares Short15.24M

Short (prev mo.)14.10M

Technical

SMA 5013.36 (-13.6%)

SMA 2009.931 (+16.3%)

Beta2.55

S&P 52W Chg14.58%

Avg Vol (30d)2.64M

Avg Vol (10d)2.84M

Technical Indicators

RSI (14)37.0

MACD-0.3089

MACD Signal0.0014

MACD Hist.-0.3104

BB Upper15.65 USD

BB Middle13.66 USD

BB Lower11.68 USD

BB Width29.10%

ATR (14)0.7708 USD

Vol Ratio (20d)0.81x